AbbVie will invest $1.4 billion to build a manufacturing campus in North Carolina, the ‌drugmaker said on Wednesday, marking ...
On Wednesday, pharma giant AbbVie announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus ...
The US Food and Drug Administration (FDA) has issued warning letters to several drug manufacturers and compounders for ...
AbbVie plans to build a $1.4 billion, 185-acre pharmaceutical manufacturing campus in Durham, North Carolina. The project ...
Bright Path, a U.S.-based advanced pharmaceutical manufacturer, today applauded the President's Fiscal Year 2027 budget proposal for its significant investments in advanced manufacturing technologies ...
AbbVie today announced a $1.4 billion investment to build a new drug production facility on a 185-acre campus in Durham County, where the company expects to employ 734 people. The company’s ...
The US Food and Drug Administration (FDA) has issued a warning letter to Purolea Cosmetics Lab for several violations of Good ...
Manufacture drugs in their own parking lot. Mr. Cuban’s Cost Plus Drugs previously launched a Dallas-based manufacturing ...
The FDA began accepting requests Feb. 1 to participate in its PreCheck pilot program, an initiative aimed at streamlining regulatory review for new U.S.-based pharmaceutical manufacturing facilities.
Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...
AbbVie (ABBV) on Wednesday announced plans to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina, at a cost of $1.4B, marking its first major investment in the state. The ...